ORBIMED ADVISORS LLC sold 2.9% of their position (108.07K shares) of SIONNA THERAPEUTICS, INC. on the open market
Open‑market sale worth $4.81M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 11/26/2025ACC: 0000947871-25-001045
Director
Since Feb 2026
-108.07K
Net shares
Net seller
$4.81M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
108.07K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−94.58K
Price / share
$44.54
Trade value
$4.21M
% of position
2.6%
11/24/2025
3.70M→3.61M
Common Stock
Indirect
Shares
−11.89K
Price / share
$44.60
Trade value
$530.29K
% of position
0.3%
11/25/2025
3.61M→3.60M
Common Stock
Indirect
Shares
−1.60K
Price / share
$44.49
Trade value
$71.18K
% of position
0.0%
11/26/2025
3.60M→3.60M
Total
Net shares
−108.07K
Net value
-$4.81M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/24/2025 | S · Sale | −94.58K | $44.54 | $4.21M | 2.6% | 3.70M | 3.61M |
| Common Stock Indirect | 11/25/2025 | S · Sale | −11.89K | $44.60 | $530.29K | 0.3% | 3.61M | 3.60M |
| Common Stock Indirect | 11/26/2025 | S · Sale | −1.60K | $44.49 | $71.18K | 0.0% | 3.60M | 3.60M |
| Total | −108.07K | -$4.81M | ||||||
Derivative Transactions0
No derivative transactions reported